Coverage
-
September 30, 2019
A New Jersey federal judge has thrown out a shareholder's derivative suit alleging Johnson & Johnson improperly sold talcum powder despite its purported cancer link, because the investor did not previously call on the company's board to take action over such claims.
1 other articles on this case.
View all »